FDA Inspection 1243575 — Cohance Lifesciences Limited

Cohance Lifesciences Limited — FEI 3019037664

The FDA completed an inspection of Cohance Lifesciences Limited on Jul 12, 2024 in Rangareddy District. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 12, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Rangareddy District (India)

Citations

IDCFRDescription
126321 CFR 211.68(b)Computer control of master formula records
187921 CFR 211.180(c)Records not made readily available to FDA